News from trialspark A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 10, 2022, 08:00 ET TrialSpark licenses sprifermin, an investigational first-in-class disease modifying treatment for osteoarthritis, from Merck KGaA, Darmstadt, Germany and announces formation of High Line Bio

TrialSpark announced today the formation of High Line Bio following the acquisition of worldwide rights to sprifermin from Merck KGaA, Darmstadt,...

Dec 08, 2021, 11:09 ET TrialSpark hires two new executives to join the company's leadership team, Gavin Corcoran, MD (Chief Medical Officer) and James Leslie, MBA (Chief Financial Officer)

TrialSpark is building a next generation pharma company focused on bringing new treatments to patients faster and more efficiently. Despite the...

Sep 30, 2021, 10:36 ET TrialSpark raises $156MM Series C Funding led by Sam Altman and Lachy Groom

TrialSpark announced today that it has raised $156MM in Series C funding. Sam Altman and Lachy Groom led the round, with participation from new and...

May 26, 2021, 08:30 ET TrialSpark and Sanofi announce collaboration to accelerate COPD clinical development

TrialSpark Inc., a tech-enabled drug development company dedicated to improving the speed, quality, and innovation of clinical trials, announced a...

Apr 20, 2021, 13:31 ET TrialSpark appoints Steven Holtzman as Sr. Advisor to the company

In the news release, TrialSpark announces addition of key strategic advisor Steve Holtzman, issued 20-Apr-2021 by TrialSpark over PR Newswire, we are ...

Dec 16, 2020, 09:05 ET Aditum Bio launches third company, Anteris Bio, in collaboration with TrialSpark

TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality, and innovation of clinical trials, formally announces...

Jul 28, 2020, 08:45 ET resTORbio and TrialSpark collaborate to investigate RTB-101 for COVID-19 on the Project Covalence platform

TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality, and innovation of clinical trials, today announced a...

Jul 21, 2020, 08:00 ET Dr. Michael Mina of the Harvard T.H. Chan School of Public Health, supported by OpenResearch, Project Covalence and TrialSpark, announces enrollment of first 500 patients of a COVID-19 serological surveillance study

Dr. Michael Mina of the Harvard T. Chan School of Public Health announced today the successful enrollment of the first 500 patients just 10 days...

Jun 16, 2020, 05:45 ET TrialSpark announces launch of Project Covalence, a clinical trial platform to rapidly test drugs and diagnostics for COVID-19

TrialSpark, a tech-enabled drug development company committed to improving the speed, quality, and innovation of clinical trials, today announced the ...

Nov 07, 2019, 08:00 ET TrialSpark Bolsters Executive Team and Industry Experience with Two Key Hires

TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality and innovation of clinical trials, announced today the...

Oct 22, 2019, 08:03 ET TrialSpark announces collaboration with Limbix on conducting an end-to-end clinical trial on Limbix's digital therapeutic for adolescent depression

TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality, and innovation of clinical trials, and Limbix, a...

Sep 26, 2019, 05:45 ET 23andMe and TrialSpark Announce Joint Clinical Trial Offering and Request For Proposals

23andMe, the leading consumer genetics company, and TrialSpark, a technology company enabling physician practices to become clinical trial sites, are ...

Sep 17, 2019, 08:03 ET TrialSpark and Pfizer collaborating to improve speed and access to clinical trials

TrialSpark, a technology company committed to improving the speed, access, and reliability of clinical trials, and Pfizer have entered into a...

Dec 11, 2018, 09:00 ET TrialSpark Joins Forces with Leading Global Healthcare Company to Work to Potentially Bring Novel Treatments to Patients Faster

TrialSpark, a New York-based technology company that has built a new model for managing and operating clinical trials, today announced the activation ...